Cannabis trial launched in patients with MS
BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7280.192/c (Published 27 January 2001) Cite this as: BMJ 2001;322:192
- Owen Dyer
- London
The world's biggest clinical trial of the cannabis plant got under way this week at Derriford Hospital, Plymouth; the trial is looking at the control of pain and tremors in multiple sclerosis. Twenty patients were given their first doses of capsules containing cannabis oil, tetra hydro cannabinol, or placebo. After three months, if all goes to plan, the trial will be slowly extended across the country, eventually taking in 660 participants in 40 centres.
The cannabis in multiple sclerosis (CAMS) study is sponsored by the Medical Research Council and approved by …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (inc. VAT)
You can download a PDF version for your personal record.